Driessen, C., Kraus, M., Joerger, M., Rosing, H., Bader, J., Hitz, F., . . . Mey, U. J. (2016). Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: A phase I trial (SAKK 65/08). Haematologica.
Chicago Style aipamenaDriessen, Christoph, et al. "Treatment With the HIV Protease Inhibitor Nelfinavir Triggers the Unfolded Protein Response and May Overcome Proteasome Inhibitor Resistance of Multiple Myeloma in Combination With Bortezomib: A Phase I Trial (SAKK 65/08)." Haematologica 2016.
MLA aipamenaDriessen, Christoph, et al. "Treatment With the HIV Protease Inhibitor Nelfinavir Triggers the Unfolded Protein Response and May Overcome Proteasome Inhibitor Resistance of Multiple Myeloma in Combination With Bortezomib: A Phase I Trial (SAKK 65/08)." Haematologica 2016.